No headlines found.
Aemetis Named 7th Hottest Company in the Bioeconomy at Advanced Bioeconomy Leadership Conference
Globe Newswire (Thu, 31-Oct 10:49 AM ET)
Aemetis Biogas Completes Initial Construction Phase of Multi-Dairy Digester
Globe Newswire (Thu, 3-Oct 8:15 AM ET)
California Can Reduce Gasoline Prices by Adopting E-15 Ethanol Blend
Globe Newswire (Tue, 24-Sep 8:00 AM ET)
Aemetis Reports Revenues of $66 Million for the Second Quarter 2024
Globe Newswire (Thu, 1-Aug 9:38 AM ET)
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into advanced biorefineries. It owns and operates an approximately 65 million gallon per year ethanol production facility located in Keyes, California. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. It operates in the reportable geographic segments of North America and India.
Aemetis trades on the NASDAQ stock market under the symbol AMTX.
As of October 31, 2024, AMTX stock price climbed to $2.78 with 197,154 million shares trading.
AMTX has a beta of 3.72, meaning it tends to be more sensitive to market movements. AMTX has a correlation of 0.25 to the broad based SPY ETF.
AMTX has a market cap of $131.21 million. This is considered a Micro Cap stock.
Last quarter Aemetis reported $67 million in Revenue and -$.66 earnings per share. This fell short of revenue expectation by $-10 million and missed earnings estimates by -$.28.
In the last 3 years, AMTX traded as high as $23.33 and as low as $1.16.
The top ETF exchange traded funds that AMTX belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
AMTX has underperformed the market in the last year with a return of -39.4%, while the SPY ETF gained +38.9%. In the last 3 month period, AMTX fell short of the market, returning -18.7%, while SPY returned +5.5%. However, in the most recent 2 weeks AMTX has outperformed the stock market by returning -1.1%, while SPY returned -2.1%.
AMTX support price is $2.59 and resistance is $2.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AMTX shares will trade within this expected range on the day.